The prevalence and associated factors of depression among patients with schizophrenia in Addis Ababa, Ethiopia, cross-sectional study

Fanta, Tolesa; Bekele, Desalegn; Ayano, Getinet

doi:10.1186/s12888-019-2419-6

Cited by 9 publications

(5 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to earlier research, depressed people have a persistently pessimistic view and a propensity to misattribute unpleasant occurrences and experiences to internal causes [52], which may impair how well they assess their own well-being. Concerning schizophrenia patients, in particular, several studies have found that individuals with schizophrenia who also have comorbid depression experience a lower quality of life compared to those who do not have depression [53][54][55]. Less depressive symptoms and a higher quality of life in schizophrenia patients can indicate an earlier recovery and improved wellbeing [56].…”

Section: Discussionmentioning

confidence: 99%

The Indirect Effect of Depression between Nightmares and Well-Being in Lebanese Patients with Schizophrenia

Mahfoud¹,

Ahdab

Helwe

et al. 2023

Perspectives in Psychiatric Care

View full text Add to dashboard Cite

Background. Because nightmares seem to be associated with depression in schizophrenia, detecting them early in therapeutic practice might be critical to ensuring effective avoidance of the development of depressive symptomatology. This helps promote well-being and improve the patient’s quality of life and illness prognosis. Therefore, the aim of this study was to examine the indirect effect of depression between nightmares and well-being in a Lebanese sample of patients with schizophrenia. Method. This monocentric cross-sectional study, conducted in July 2022, enrolled patients with chronic schizophrenia admitted to the Psychiatric Hospital of the Cross. Data were collected from a total of 148 participants through face-to-face interviews. The questionnaire included a nightmares measure, PSYRATS, Calgary depression scale for schizophrenia, PTSD checklist for DSM-5, the digit span subset, and WHO-5Well-Being Index. Results. The presence of nightmares was significantly associated with more depression, whereas higher depression was significantly associated with lower well-being. It is noteworthy that the presence of nightmares was not directly associated with well-being. Conclusion. Nightmares lead indirectly to lower well-being in schizophrenia patients, with depression serving as a mediating factor in this association. This suggests that interventions aiming at improving dream content may also have a beneficial effect in reducing depression in schizophrenia leading therefore to better well-being of the patients.

show abstract

Section: Discussionmentioning

confidence: 99%

The Indirect Effect of Depression between Nightmares and Well-Being in Lebanese Patients with Schizophrenia

Mahfoud¹,

Ahdab

Helwe

et al. 2023

Perspectives in Psychiatric Care

View full text Add to dashboard Cite

show abstract

“…For example, in a cross-sectional study that aimed to estimate the prevalence of depression in a rural community in Ethiopia, the researchers used a sample size formula based on the expected prevalence, margin of error, and confidence level to calculate the sample size. They determined that a sample size of 384 was needed to estimate the prevalence of depression with a 5% margin of error and 95% confidence level (Mekonnen et al, 2019).…”

Section: Cross-sectional Studiesmentioning

confidence: 99%

El cálculo del tamaño de la muestra en la investigación científica.

Gamboa Graus

2023

dilemas

View full text Add to dashboard Cite

Este artículo proporciona una visión general de los enfoques comunes y los factores que afectan la determinación del tamaño de la muestra en varios diseños de estudio, incluyendo estudios experimentales, observacionales, cualitativos y de encuesta. Se discute la metodología utilizada para determinar el tamaño de muestra, junto con los desafíos, limitaciones e importancia de informar la determinación del tamaño de muestra en los estudios de investigación y proporciona pautas para hacerlo. El artículo concluye con la necesidad de que los investigadores consideren cuidadosamente la determinación del tamaño de muestra al diseñar estudios para garantizar resultados válidos y confiables. El artículo proporciona un recurso útil para investigadores y profesionales involucrados en el diseño e implementación de estudios.

show abstract

“…In this study, severe psychiatric disorders were assessed by using the structured clinical interview for DSM-ΙѴ-TR axis Ι disorders (SCID) [30]. SCID which is a validated and standard diagnostic tool to assess DSM-IVaxis I disorders (major psychiatric disorders) and it has been extensively utilized to assess psychiatric disorders in previous studies in Ethiopia [31][32][33][34][35].…”

Section: Screening For Severe Psychiatric Disordersmentioning

confidence: 99%

Undiagnosed HIV, hepatitis B, and hepatitis C infections in people with severe psychiatric disorders in Ethiopia

Ayano

Haile²,

Tesfaye

et al. 2020

BMC Infect Dis

Self Cite

View full text Add to dashboard Cite

Background: Worldwide, there is limited epidemiologic evidence on the seroprevalence of undiagnosed chronic viral infections including HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among patients with severe psychiatric disorders. To our knowledge, this is the first study to explore and compare undiagnosed seroprevalence rates of HIV, HBV, and HCV infections among patients with severe psychiatric disorders. Method: In this study, we included a random sample of 309 patients with severe psychiatric disorders selected by systematic sampling technique. We used a structured clinical interview for DSM-IV (SCID) to confirm the diagnosis of severe psychiatric disorders among the participants. Binary and multivariable logistic regression models, adjusting for the potential confounding factors was used to explore the potential determinants of chronic viral infections. Result: The prevalence estimates of HIV infection among patients with severe psychiatric disorders in this study (3.24%) was roughly 3 times the estimated population prevalence of HIV infection in Ethiopia (1.1%). This study showed that the prevalence rates of HBV and HCV infections among patients with severe psychiatric disorders were 4.85 and 1.29%, respectively. Our results also showed that among patients with chronic viral infections, HIV, HBV and HCV, 76.92, 60, 80, and 75% respectively were undiagnosed. Regarding associated factors, the presence of chronic viral infection was found to be significantly associated with the age of the participants (ranging between 30 and 40 years) after adjusting for the possible confounding factors [AOR = 3.95 (95%CI.18-13.17)]. Conclusion: Even though the prevalence estimates of HIV (3.24%), HBV (4.85%), and HCV (1.29%) infections were high among patients with severe psychiatric disorders, the majority of them remained undiagnosed. HBV was found to be the commonly undiagnosed infection (4 out of 5) followed by HCV (3 out of 4) and HIV (6 out of 10). The present study provided evidence of a significant association between the age of the participant (between 30 and 40 years) and chronic viral infections in patients with severe psychiatric disorders. Increasing the awareness of psychiatry professionals and early screening, as well as interventions of chronic viral infections among patients with severe psychiatric disorders are imperative.

show abstract

The prevalence and associated factors of depression among patients with schizophrenia in Addis Ababa, Ethiopia, cross-sectional study

Cited by 9 publications

References 30 publications

The Indirect Effect of Depression between Nightmares and Well-Being in Lebanese Patients with Schizophrenia

The Indirect Effect of Depression between Nightmares and Well-Being in Lebanese Patients with Schizophrenia

El cálculo del tamaño de la muestra en la investigación científica.

Undiagnosed HIV, hepatitis B, and hepatitis C infections in people with severe psychiatric disorders in Ethiopia

Contact Info

Product

Resources

About